Peripheral chemoreceptor function after carbonic anhydrase inhibition during moderate-intensity exercise. J. Appl. Physiol. 86(5): 1544-1551 , 1999 .-The effect of carbonic anhydrase inhibition with acetazolamide (Acz, 10 mg/kg) on the ventilatory response to an abrupt switch into hyperoxia (end-tidal PO 2 ϭ 450 Torr) and hypoxia (end-tidal PO 2 ϭ 50 Torr) was examined in five male subjects [30 Ϯ 3 (SE) yr]. Subjects exercised at a work rate chosen to elicit an O 2 uptake equivalent to 80% of the ventilatory threshold. Ventilation (V E) was measured breath by breath. Arterial oxyhemoglobin saturation (%Sa O 2 ) was determined by ear oximetry. After the switch into hyperoxia, V E remained unchanged from the steady-state exercise prehyperoxic value (60.6 Ϯ 6.5 l/min) during Acz. During control studies (Con), V E decreased from the prehyperoxic value (52.4 Ϯ 5.5 l/min) by ϳ20% (V E nadir ϭ 42.4 Ϯ 6.3 l/min) within 20 s after the switch into hyperoxia. V E increased during Acz and Con after the switch into hypoxia; the hypoxic ventilatory response was significantly lower after Acz compared with Con [Acz, change (
INHIBITION OF CARBONIC ANHYDRASE (CA), the enzyme responsible for the rapid hydration of CO 2 and dehydration of bicarbonate (HCO 3 Ϫ ), results in increased minute ventilation (V E) and a fall in alveolar PCO 2 in dogs (1) and humans (17, 18, 20) . Although the effect of CA inhibition on CO 2 transport and reaction kinetics during exercise in humans has been previously investigated (18) , the mechanism(s) mediating the ventilatory response after CA inhibition is less well described.
We recently reported (14) that acute CA inhibition with acetazolamide (Acz) slows the rate of adaptation of V E and pulmonary CO 2 output (V CO 2 ) for a step increase in work rate from loadless to moderate-intensity exercise. Because the peripheral chemoreceptors (pR c ) mediate the kinetics of ventilatory response to a step increase in work rate (5, 26) , it remains possible that the slowed V E kinetics after Acz may reflect reduced pR c chemosensitivity. The most widely used noninvasive method for determining the contribution of the pR c to the ventilatory drive is the Dejours O 2 test (3). The Dejours test assumes that the drive to breathe from the pR c is effectively silenced by an abrupt switch in the inspirate from either hypoxia or euoxia to 100% O 2 (3) . The magnitude of the transient ventilatory decline, the nadir of which is reached in ϳ20 s after the hyperoxic exposure, is a measure of the ventilatory drive arising from the pR c before the hyperoxic bout (for review see Refs. 23, 28) .
Recently, Swenson and Hughes (17) examined the effect of acute Acz administration on the ventilatory response to hypoxia, and to hypercapnia in a background of hyperoxia and of hypoxia in humans under resting conditions. Compared with the uninhibited condition, acute Acz administration resulted in a similar hyperoxic hypercapnic ventilatory response and reduced hypoxic hypercapnic ventilatory response. Furthermore, the eucapnic hypoxic ventilatory response (HVR) was completely abolished by acute Acz administration (17) . It was concluded from these observations that CA inhibition resulted in an attenuated pR c response. These findings are consistent with studies in animal models that have demonstrated, by direct measurement of carotid body output, reduced pR c activity after CA inhibition with Acz (19, 21) .
Few studies have examined ventilatory control mechanisms in humans after Acz administration (17, 20) , and none has examined the ventilatory response during moderate-intensity exercise after the acute administration of Acz. Moderate-intensity exercise was used in the present study to determine whether the slowed V E kinetics observed previously at exercise onset after acute Acz administration (14) could be attributed in part to an Acz-induced attenuation of the pR c drive. Therefore, the first purpose of the present study was to utilize a modified Dejours O 2 test to determine the peripheral chemoreflex contribution to the ventilatory drive after Acz-induced CA inhibition. Second, we wished to extend the previous findings of an Acz-induced suppression of the HVR under resting conditions (17) to conditions during moderate-intensity exercise, thereby further demonstrating a role for CA in the ventilatory response to hypoxia.
METHODS

Subjects and protocol.
Five male subjects participated in this study. All subjects were nonsmokers with no prior history of cardiovascular or respiratory disease. The study requirements, experimental protocol, and all possible risks associated with participation in the study were outlined, and informed consent was obtained from each subject participant. The research protocol was approved by the University's Review Board for Health Sciences Research involving Human Subjects.
Preliminary testing of each subject was performed for the determination of peak O 2 uptake (V O 2 ) and the ventilatory threshold (V ET) by using a progressive exercise test to volitional fatigue on an electrically braked cycle ergometer (model H-300-R, Lode) in which the work rate was increased as a ramp function at a rate of 25 W/min. The V ET was defined as the V O 2 at which there was a systematic increase in the ventilatory equivalent for V O 2 (V E/V O 2 ) and end-tidal PO 2 (PET O 2 ), with no concomitant increase in the ventilatory equivalent for V CO 2 (V E/V CO 2 ) or decrease in end-tidal PCO 2 (PET CO 2 ).
The subjects reported to the laboratory after consuming only a light meal and abstaining from exercise and beverages containing caffeine for at least 12 h preceding the test. The exercise tests were performed at the same time of the day for each subject. Before each of the Acz studies, the subjects rested supine while a percutaneous Teflon catheter (Angiocath, 21 gauge) was placed into a dorsal hand vein followed by Acz infusion (10 mg/kg iv over a 3-min period). The subjects rested for a further 30 min (15 min supine, 15 min upright) before being moved to the cycle ergometer.
The subjects performed a step increase in work rate from a baseline of loadless pedaling to a work rate estimated to elicit a V O 2 equal to 80% of V ET. The exercise intensity was chosen to avoid the additional complications associated with a sustained lactic acidosis that accompanies heavy exercise and was similar to the exercise intensity used previously (14) . A schematic of the hyperoxia-hypoxia experimental protocol is presented in Fig. 1 . After 6 min of accommodation to exercise and euoxia (i.e., PET O 2 set to ϳ100 Torr), inspired PO 2 was abruptly increased to achieve an PET O 2 of 450 Torr for a duration of 8 min. A 6-min euoxic recovery period followed the hyperoxic step, after which the subject was given a 2-min hypoxic step (PET O 2 ϭ 50 Torr). The protocol ended with 2 min of euoxic recovery. Throughout the test, PET CO 2 was not clamped (i.e., poikilocapnic).
Respiratory apparatus and gas analysis. During testing, subjects were seated on a cycle ergometer and breathed through a mouthpiece with the nose occluded. Inspired and expired ventilation flow rates were measured by using a low-resistance, low-dead-space (90 ml) bidirectional turbine (VMM 110, Alpha Technologies) and volume transducer (VMM-2A, Sensor Medics), which were calibrated before each test by using a syringe of known volume (3.01 liters). Respiratory flow and timing were determined by using a pneuomotachograph (model 3800, Hans Rudolph) and a differential pressure transducer (MP45-871, Validyne). Inspired and expired air were sampled continuously (20 ml/min) at the mouth and analyzed by a mass spectrometer (MGA 2000, Airspec) for fractional concentrations of O 2 , CO 2 , and N 2 . The mass spectrometer was calibrated before each test by using precision-analyzed gas mixtures. Analog signals from the turbine, pressure transducer, and mass spectrometer were sampled and digitized every 20 ms by computer. Breath-by-breath computations for pulmonary gas exchange (V O 2 , V CO 2 ) and V E were performed after delays in the analysis system and fluctuations in lung gas stores in the computer algorithms were accounted for (15) . Corrections for temperature and water vapor pressure were made for conditions measured near the mouth. Heart rate was continuously monitored by using an electrocardiogram with electrodes placed in a modified V5 configuration. Arterial oxyhemoglobin saturation (Sa O 2 ) was measured noninvasively by using an ear probe (OXI3 Pulse Oximeter, Radiometer).
Two computers were used during testing. A data-acquisition computer collected the experimental variables every 20 ms and stored them on disk for later analysis. PET O 2 was accurately controlled by using a computer-controlled fast gas-mixing system, which was similar to that previously described in detail (13) . The control computer compared the actual measured PET O 2 with the target PET O 2 , which was entered into a forcing function program before the start of the experimental protocol. The difference between the measured and target PET O 2 served as the feedback signal, determined at the end of each breath, from which the control computer adjusted the gas mixture to force the PET O 2 toward the target value. The inspired PO 2 required to achieve the desired PET O 2 was converted by an algorithm into appropriate values for Fig. 1 . Schematic representation of poikilocapnic hyperoxic and hypoxic protocol. After 2 min of rest (not shown), 2 min of loadless cycling were initiated, and end-tidal PO 2 (PET O 2 ) was clamped at ϳ100 Torr. End-tidal PCO 2 (PET CO 2 ) was not controlled during the protocol (i.e., poikilocapnic). At 2 min, a step transition in work rate corresponding to O 2 uptake at 80% of ventilatory threshold (V ET) was initiated, which was performed for the remainder of the protocol. At minute 6 of moderateintensity exercise, an abrupt hyperoxic step (PET O 2 ϭ 450 Torr) occurred, lasting for 8 min. After the hyperoxic bout, PET O 2 was returned to ϳ100 Torr for a 6-min period. After this recovery period, a 2-min step into hypoxia (PET O 2 ϭ 50 Torr) was performed, which was followed by 2 min of recovery with PET O 2 returned to ϳ100 Torr. flows of O 2 and N 2 . PET CO 2 was not controlled in the present study.
Data analysis. The experimental protocol was repeated twice during each visit to the laboratory on two separate occasions for each of the control (Con) and Acz conditions. For each subject, the breath-by-breath data for each condition were time aligned, interpolated over 1-s intervals, and ensemble averaged to yield a single response for each subject per condition to increase the signal-to-noise ratio. The prehyperoxic and prehypoxic V E were taken as the mean (determined from the ensemble-averaged response for each subject) during the last 30 s before the hyperoxic and hypoxic step, respectively. Previous work from our laboratory (16) has shown that the nadir in V E typically occurs within 20-30 s of the switch into hyperoxia and that no difference is observed in the nadir with the use of either 1-or 5-s averaged data for determination of the decline in V E. Thus the data during hyperoxia were averaged over 5-s intervals from time 0 to 1 min, over 15-s intervals from 1 to 3 min, and over 30-s intervals from 3 to 8 min. The nadir of the individual ventilatory response to hyperoxia, determined from the 5-s mean data, was analyzed by using Student's paired t-test. The HVR was determined from the changes in V E, PET O 2 (⌬V E/⌬PET O 2 ), and Sa O 2 (⌬V E/⌬Sa O 2 ) averaged over the last 60 s of hypoxia. Differences in the HVR between Con and Acz were analyzed by using Student's paired t-test. Statistical significance was accepted at P Ͻ 0.05. All values are reported as means Ϯ SE.
RESULTS
The physical characteristics of the subjects and the results of the maximal ramp exercise test are presented in Table 1 . The work rate for the moderate-intensity, constant-load exercise tests corresponded to the V O 2 at 80% of the V ET (76.9 Ϯ 2% V ET) and ranged from 132 to 197 W for the five subjects. The group mean response to the hyperoxic-hypoxic experimental protocol is presented in Fig. 2 .
Ventilatory response during loadless cycling. The effects of acute Acz administration on V E, breathing pattern, and gas exchange are presented in Table 2 . Compared with Con, acute Acz administration resulted in a higher V E (14.6%) during loadless cycling. The higher V E was attributed to the 13.3% higher tidal volume during Acz, because there were no differences in either inspiratory or expiratory duration or breathing frequency between conditions. At the onset of loadless cycling and during moderate-intensity exercise, PET O 2 was set at ϳ100-105 Torr, resulting in similar values for Con and Acz conditions throughout the test. During loadless cycling, Acz resulted in a lower PET CO 2 than did Con. Although V O 2 and V CO 2 were unchanged from Con conditions with Acz, the ventilatory equivalents for V O 2 (V E/V O 2 ) and V CO 2 (V E/V CO 2 ) were higher during Acz than Con because of the higher V E after Acz administration.
Ventilatory response during steady-state exercise and hyperoxia. All subjects achieved a steady-state response (i.e., V E, V CO 2 , and V O 2 ) to the step increase in exercise intensity within ϳ4 min of the onset of the transition. The effects of acute Acz administration on V E, breathing pattern, and gas exchange during steadystate exercise (i.e., prehyperoxic values) are presented in Table 3 . During the 30-s interval before hyperoxia, V E was 15.4% higher during Acz than Con, which is attributed to the 16.5% higher tidal volume during Acz compared with Con; breath timing (inspiratory and expiratory time) and breathing frequency were similar between conditions. With exercise, PET CO 2 increased above loadless cycling values during both Acz and Con conditions; PET CO 2 was lower during Acz compared with Con.
During the hyperoxic step (PET O 2 ϳ450 Torr), V E remained unchanged from prehyperoxic values during Acz (Table 4 , Fig. 3 ). In contrast, V E decreased transiently during Con (9.9 Ϯ 1.5 l/min; 20.4 Ϯ 4.4%) before returning to prehyperoxic values (Table 4 , Fig. 3) . In all subjects, the nadir of the individual V E response was observed within 20-25 s after the step into hyperoxia.
Ventilatory response during steady-state exercise and hypoxia. After the hyperoxic bout, the PET O 2 was returned to ϳ100-105 Torr for 6 min to establish a steady state before the hypoxic step. The effects of acute Acz administration on V E, breathing pattern, and gas exchange during steady-state exercise before the hypoxic step were similar to conditions before the hyperoxic period ( Table 3) .
The HVR results are presented in Fig. 4 . The HVR was lower after Acz than Con as indicated by both the ⌬V E/⌬PET O 2 and ⌬V E/⌬Sa O 2 . There were no differences between Acz and Con conditions during hypoxia for either PET O 2 (Acz, 49.3 Ϯ 0.3 Torr; Con, 49.2 Ϯ 1.1 Torr) or Sa O 2 (Acz, 78.3 Ϯ 0.9%; Con, 78.5 Ϯ 0.9%). Thus the reduced HVR during Acz was attributed to a lower ⌬V E, despite the higher absolute V E induced by the administration of Acz.
The PET CO 2 response agreed with the ventilatory response such that the fall in PET CO 2 was less (P Ͻ 0.05) during Acz (⌬PET CO 2 , 5.7 Ϯ 1.2 Torr) compared with Con 
DISCUSSION
This study examined the effect of CA inhibition after an acute administration of Acz on the hyperoxic ventilatory response and HVR in the steady state of moderateintensity exercise in humans. The results of this study suggest that, in humans, acute Acz administration (at a dose of 10 mg/kg) effectively abolishes the ventilatory response to hyperoxia and reduces the ventilatory response to hypoxia, probably by a reduced drive from the peripheral chemoreflex (pR c ).
Limitations due to CA inhibition. The experiment was begun 30 min after an acute infusion of Acz to examine the ventilatory response to acute CA inhibition without the confounding effects of a metabolic Fig. 2 . Mean ventilatory, PET CO 2 , and PET O 2 responses to hyperoxic and hypoxic protocol during control (A) and after acute acetazolamide administration (B). Mean response represents individual subject responses, which were interpolated to 1-s intervals and ensemble averaged, with each subject contributing 4 repetitions for each of control and acetazolamide conditions. Dotted lines represent onset and end of hyperoxic and hypoxic challenges, respectively. (6, 14) . The determination of Pa CO 2 and pH in vivo is complicated by the fact that the effective inhibition of erythrocyte CA activity results in CO 2 -HCO 3 Ϫ disequilibrium. The incomplete equilibration of CO 2 species between erythrocytes and plasma during the transit through the pulmonary capillaries causes a widening of the arterial-alveolar PCO 2 difference, particularly at higher exercise intensities (18) . This apparent arterial-alveolar PCO 2 difference reflects the measurements made at equilibrium but does not reflect the in vitro conditions at the time of sampling.
As a consequence of the CO 2 -HCO 3 Ϫ disequilibrium in the postpulmonary capillary blood, it is not possible to accurately determine the Pa CO 2 or pH that either the pR c or central chemoreceptor (cR c ) may be sensing. Swenson and Maren (18) calculated the half-time for the dehydration reaction of HCO 3 Ϫ to CO 2 to be 1.5 and 0.4 s for rest and maximal exercise, respectively. Because the lung-to-carotid-body transit time is ϳ7 s in moderate-intensity exercise (24, 29) , the predicted level of PCO 2 that either the pR c or cR c is sensing would be higher than that estimated from PET CO 2 . Whether the magnitude of the rise in Pa CO 2 would be great enough to cause an equivalent level of stimulation at the carotid bodies during Acz and Con cannot be determined with certainty from the results of this study. However, if the assumption is made that the pR c and cR c are sensing Pa CO 2 values close to the equilibrated value, then the results of our previous study (14) suggest that the Pa CO 2 is actually higher at the chemoreceptor sites during Acz than Con.
We did not measure CA activity; however, we estimate, assuming an even distribution of Acz in the vascular and extracellular compartment, that the extracellular fluid concentration of Acz would be ϳ225 µmol/l (or ϳ45 µmol/kg). The dose of Acz used in the present study (10 mg/kg Acz) would result in a plasma concentration of Acz severalfold higher than required to inhibit Ͼ99.95% of the total erythrocyte CA activity (30) . In addition, the dose used in the present study was similar to that used in a study by Maren and Swenson (18) in which they reported the erythrocyte isozymes CA I and CA II to be ϳ93.3 and 99.3% inhibited, respectively, with a dose of 7-10 mg/kg Acz. Mean Ϯ SE 52.4 Ϯ 5.5 42.4 Ϯ 6.3 Ϫ20.4 Ϯ 4.4 60.6 Ϯ 6.5* 60.5 Ϯ 6.5* Ϫ0.2 Ϯ 0.8* Ventilatory nadir during Control was taken as the lowest V E after the onset of hyperoxia and was compared with the V E at the same time during Acetazolamide. V E pre, before V E. * Significantly different from Control (P Ͻ 0.05). Fig. 3 . Group mean (ϮSE) ventilatory response before (Pre) and during hyperoxic step during control (r) and after carbonic anhydrase inhibition with acetazolamide (s). Dotted line represents onset of hyperoxic challenge.
The purpose of this study required human subjects to perform whole body exercise, and thus a further limitation is our inability to state with certainty which CA isozymes (other than erythrocyte isozymes) may have been affected by the infusion of Acz. Specifically, CA has been localized in the glomus cells of the carotid bodies (9, 12) and in glial cells neighboring the cR c (4), both which may be susceptible to Acz administration.
Ventilatory response to hyperoxia. A unique finding of this study was that a transient decrease in V E at the onset of hyperoxic breathing was completely abolished after CA inhibition. The pR c contribution to the ventilatory drive, which we found to be ϳ20%, is in close agreement with earlier estimates for moderate-intensity exercise (5, 10, 16, 25) . The results of this study provide indirect evidence for a suppression of pR c drive to breathe after acute Acz administration during moderate-intensity exercise in humans. Our results are in agreement with a previous study (17) that demonstrated a suppressed pR c drive determined by the ventilatory response to hyperoxic and hypoxic hypercapnic breathing after acute Acz administration in resting humans.
Direct assessment of peripheral and central chemoreflex output and, therefore, their role in the modulation of V E is not possible in humans. Teppema and colleagues (19) observed a reduction in pR c activity in anesthetized cats given a much larger dose of Acz (50 mg/kg) than used in the present study. However, at doses as low as 4 mg/kg (i.e., the lowest dosage possible without causing an alveolar-arterial PCO 2 gradient), a decrease in pR c sensitivity to CO 2 was still apparent in this cat preparation (22) .
We are not aware of any reports that specifically identify the mechanism of action of Acz-induced CA inhibition on the carotid bodies. Although CA is found within the glomus cells of the carotid bodies (9) , its function in chemoreception is not well understood. It has been suggested that, during CA inhibition, the uncatalyzed hydration reaction is slowed, resulting in a slowed generation of H ϩ , which is required to stimulate pH-sensitive receptors and thereby allow chemotransduction to proceed normally (8) . This mechanism may also affect the ventilatory response to hypoxia (discussed in Ventilatory response to hypoxia) because the pR c response to hypoxia is dependent on the response to CO 2 (8) .
Ventilatory response to hypoxia. In the present study, the HVR was attenuated for the same ⌬Sa O 2 and ⌬PET O 2 after Acz compared with the uninhibited condition (Fig.  4) . Suppression of hypoxic ventilatory sensitivity with Acz is consistent with CA inhibition affecting the pR c input to the central respiratory center. The complete suppression of ventilatory sensitivity and carotid body output to hypoxia has been demonstrated in anesthetized cats during Acz-induced CA inhibition (19, 21) , adding support to the contention that Acz may indeed reduce pR c activity in humans.
The blunted HVR found in the present study is in partial agreement with previous reports that have examined the possible mechanisms responsible for the mediation of the ventilatory response to CA inhibition in humans at rest (17, 20) . In contrast to the attenuated HVR with Acz in our study, Swenson and Hughes (17) reported a complete suppression of hypoxic ventilatory responsiveness under isocapnic conditions after an acute infusion of Acz in resting humans. It is difficult to reconcile the difference in the HVR between these studies. It is interesting that, in the present study, PET CO 2 was not controlled during either Con or Acz conditions; however, in the study by Swenson and Hughes, PET CO 2 was maintained at levels similar to the uninhibited condition by adding CO 2 to the inspirate, a condition that may be expected to further augment the HVR. Moreover, of significant importance in the study by Swenson and Hughes, the HVR was determined in only mild hypoxia (Sa O 2 ϭ 88%). In the present study, Sa O 2 was ϳ78%, which represents a greater hypoxic ventilatory stimulus (i.e., steep portion of the V E-alveolar PO 2 curve). In addition, Weil and colleagues (27) have shown that the HVR is potentiated when hypoxia is introduced during moderate-intensity exercise. Although these researchers suggested that the increased HVR was associated with augmented pR c sensitivity, they could not conclude that central chemoreception did not play a role.
Although the reason(s) for the varied HVR during acute Acz administration is not readily apparent, a number of factors may have contributed to the divergent ventilatory responses. Under normal conditions, hypoxia-induced increases in V E cause a progressive decrease in Pa CO 2 and arterial H ϩ concentration. Consequently, this reduction in Pa CO 2 and arterial H ϩ concentration acting at the pR c to reduce V E may result in an underestimation of the true HVR if it is not corrected for by the addition of CO 2 to the inspirate to maintain isocapnia. During Acz, PET CO 2 was lower before the hypoxic bout and, therefore, cannot be discounted as possibly attenuating the HVR during CA inhibition. We do not believe this to be the case, however, because the relative decrease in PET CO 2 during the hypoxic challenge was actually greater during Con than Acz so that at the end of the hypoxic period PET CO 2 was similar in both conditions. The wide acceptance that the interaction of hypoxia and CO 2 occurs at the carotid bodies (2) supports the notion that CA inhibition directly affects the HVR through actions at the pR c . In addition, the fact that the isocapnic HVR was completely abolished with acute Acz in resting humans (17) provides further evidence that the pR c is directly affected by CA inhibition.
Ventilatory response in hyperoxia vs. hypoxia during CA inhibition. The brief hypoxic exposure was given only 6 min after the hyperoxic bout, and, therefore, the degree of pR c inhibition should not have changed in this brief time period. Thus it is somewhat difficult to reconcile the observations that Acz completely suppressed pR c function during the step into hyperoxia but only attenuated the response during the hypoxic step. Possible mechanisms contributing to the ventilatory response to hyperoxia and hypoxia during Acz are discussed below.
Recently, Rapanos and Duffin (11) confirmed that, under resting conditions, V E does not increase in response to hypoxia if the PET CO 2 (and presumably Pa CO 2 ) is lower than the peripheral chemoreflex threshold for CO 2 of ϳ39 Torr. Determination of the peripheral chemoreflex threshold as reported by Rapanos and Duffin requires that CO 2 be rapidly equilibrated in the postpulmonary capillaries. The disequilibrium of CO 2 species in the postpulmonary capillaries consequent to CA inhibition will result in a widening of the end-tidalarterial difference as blood flows toward the pR c , and thus the PET CO 2 will underestimate the Pa CO 2 that the pR c is sensing. Although PET CO 2 was lower during Acz than Con before the hyperoxic step, PET CO 2 was similar in Acz studies before the hyperoxic (36.5 Ϯ 0.8 Torr) and hypoxic (36.9 Ϯ 0.5 Torr) bouts. The immediate increase in V E during hypoxia suggests that Pa CO 2 was not below the CO 2 threshold for pR c stimulation, and thus the lack of a ventilatory decline in hyperoxia does not appear to be a function of low CO 2 stimulus (i.e., below the CO 2 threshold).
Previous studies in resting humans (17, 20) have demonstrated a hypoxia-mediated increase in V E after chronic Acz. This finding has lead to the hypothesis that CA inhibition at the pR c is not complete, allowing for some residual activity to respond to the low PO 2 . Possibly, if the pR c response is not completely inhibited by Acz, an increase in V E may occur during severe hypoxia (PET O 2 Ͻ60 Torr), where the sensitivity of the pR c is functioning on the steep part of the V E-alveolar PO 2 curve. Similarly, reduced pR c sensitivity because of CA inhibition in combination with the relatively low gain of the pR c normally present at high O 2 levels may explain the lack of a ventilatory response to the hyperoxic step.
Summary. In summary, this study examined the effects of acute CA inhibition with Acz on the ventilatory response to poikilocapnic hyperoxia and hypoxia during moderate-intensity exercise in humans. There does not appear to be any pR c contribution to the ventilatory drive in the steady state of moderateintensity exercise after Acz-induced CA inhibition, as indicated by the failure of an abrupt hyperoxic stimulus to induce a decline in V E. However, acute Acz administration did not completely attenuate the pR c response to hypoxia. These findings suggest that CA inhibition affects ventilatory control mechanisms in humans in a very complex manner that must consider changes in acid-base status and the inhibition of pR c .
